Aims: To determine infant exposure to 6-thioguanine and 6-methylmercaptopurine nucleotides (6-TGN and 6-MMPN, respectively) during maternal use of azathioprine in breastfeeding.
Methods: Mother-infant pairs provided blood for determination of 6-TGN and 6-MMPN concentrations, and TPMT genotype.
Results: Four women taking azathioprine 1.2-2.1 mg kg(-1) day(-1) and their infants were studied. All had the wild-type TPMT genotype. Maternal 6-TGN and 6-MMPN concentrations ranged from 234 to 291 and 284 to 1178 pmol per 8 x 10(8) red blood cells, respectively, and were consistent with those associated with improved therapeutic outcomes. Neither 6-TGN nor 6-MMPN was detected in any of the infants, despite a sensitive assay.
Conclusions: The data suggest that azathioprine may be 'safe' during breastfeeding in patients with the wild-type TPMT genotype ( approximately 90% of caucasian patients) taking 'normal' doses.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885151 | PMC |
| http://dx.doi.org/10.1111/j.1365-2125.2006.02639.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessment on the use of allopurinol to improve safety and efficacy of mercaptopurine in pediatric patients with Acute Lymphoblastic Leukemia and Lymphoma during maintenance therapy.
Cancer Rep (Hoboken)
February 2024
Department of Pharmacy, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
Background: Mercaptopurine is an important component of acute lymphoblastic leukemia (ALL) and lymphoma (LLy) maintenance therapy. The 6-thioguanine nucleosides (6-TGN) are believed to be the primary contributor to myelosuppression and immunosuppressive effects, while 6-methylmercaptopurine (6-MMPN) is believed to be responsible for several toxicities including hepatotoxicity, pancreatitis, and hypoglycemia. Previous reports suggest the addition of allopurinol may reduce these toxicities.
View Article and Find Full Text PDFAzathioprine metabolite levels and outcomes during pregnancies with rheumatic disease.
Lupus Sci Med
January 2024
Department of Medicine, Duke University, Durham, North Carolina, USA.
Article Synopsis
- This study investigates the effects of pregnancy on the metabolism of azathioprine (AZA) and its metabolites in women with rheumatic diseases, focusing on 6-thioguanine nucleotide (6-TGN) and 6-methylmercaptopurine nucleotide (6-MMPN).
- It includes data from 37 pregnancies and 108 blood samples, finding stable levels of 6-TGN but elevated levels of 6-MMPN during pregnancy without associated liver issues.
- The research notes a potential link between metabolite levels, maternal disease activity, and improved neonatal outcomes, although the findings on significant changes in 6-TGN levels during pregnancy were inconclusive.
Azathioprine-induced vanishing bile duct syndrome: The value of early thiopurine metabolism assessment.
Br J Clin Pharmacol
August 2023
Unité de Pharmacogénétique, Service de Biochimie, Hôpital européen Georges Pompidou, AP-HP.Centre, Université Paris Cité, Paris, France.
Article Synopsis
- A 34-year-old woman on azathioprine for lupus developed serious liver problems, leading to a diagnosis of ductopenia after blood tests showed abnormal metabolite levels.
- The case highlights the rarity of ductopenia as a side effect of azathioprine and suggests that monitoring blood levels of thiopurine metabolites could help identify patients at risk of liver damage.
Impact of Duodenal Pathology on Oral Drug Bioavailability and Disease Outcomes in Pediatric Crohn's Disease.
Pharmaceuticals (Basel)
February 2023
Children's Mercy Kansas City, Kansas City, MO 64108, USA.
Background: Crohn's disease with upper gastrointestinal tract involvement occurs more often in children than adults and has the potential to interfere with oral drug absorption. We aimed to compare disease outcomes in children receiving oral azathioprine for the treatment of Crohn's disease with (DP) and without (NDP) duodenal pathology at diagnosis.
Methods: Duodenal villous length, body mass index (BMI), and laboratory studies were compared in DP vs.
Improved HPLC Quantification of 6-Mercaptopurine Metabolites in Red Blood Cells: Monitoring Data and Literature Analysis.
Int J Mol Sci
October 2022
Department of Biological Pharmacology and Pharmacogenetics, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, 1 rue Charles Vellefaux, 75011 Paris, France.
Thiopurine drugs azathioprine (AZA) and 6-mercaptopurine (6-MP) are used extensively in pediatric and adult patients with inflammatory and neoplastic diseases. They are metabolized to 6-thioguanine nucleotides (6-TGN) or to 6-methyl-mercaptopurine nucleotides (6-MMPN). The balance between 6-TGN and 6-MMPN is highly variable and monitoring is recommended, but its benefit in outcome gives rise to conflicting results, potentially increased by differences in quantifying 6-MP metabolism.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!